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Abstract
 
Multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis
(EAE), are inflammatory diseases of the central nervous system (CNS) characterized by local-
ized areas of demyelination. The mechanisms underlying oligodendrocyte (OLG) injury in MS
and EAE remain unknown. Here we show that caspase-11 plays crucial roles in OLG death
and pathogenesis in EAE. Caspase-11 and activated caspase-3 were both expressed in OLGs in
spinal cord EAE lesions. OLGs from caspase-11–deficient mice were highly resistant to the cell
death induced by cytotoxic cytokines. EAE susceptibility and cytokine concentrations in the
CNS were significantly reduced in caspase-11–deficient mice. Our findings suggest that OLG
death is mediated by a pathway that involves caspases-11 and -3 and leads to the demyelination
observed in EAE.
Key words: apoptosis • cytokines • experimental autoimmune encephalomyelitis • multiple 
sclerosis • knockout mouse
 
Introduction
 
Multiple sclerosis (MS)
 
1
 
 and its animal model, experimen-
tal autoimmune encephalomyelitis (EAE), are T cell–medi-
ated inflammatory diseases of the central nervous system
 
(CNS). Although apoptosis in EAE lesions has been
reported, the mechanism that leads to oligodendrocyte
(OLG) injury remains to be determined (1, 2). We have
 
generated transgenic mice that express the baculovirus
antiapoptotic, caspase-inhibitory protein p35 in OLGs
 
through the Cre-
 
loxP
 
 system (3). p35-expressing OLGs
derived from transgenic mice were resistant to cytotoxic
cytokine–induced cell death. These mice were also resis-
tant to EAE induction by immunization with the myelin
OLG glycoprotein (MOG). The number of activated
caspase-3–expressing and apoptotic OLGs was reduced in
the white matter of the lumbar spinal cord. Thus, the inhi-
bition of caspases in OLGs prevents them from undergoing
cell death and ameliorates the severity of autoimmune de-
myelinating diseases. These findings raised questions about
how caspase-3 is activated and whether its activation is
critical for the pathogenesis of MS and EAE. Previously, a
reduction in the incidence and severity of EAE was ob-
served in caspase-1 knockout mice (4). However, the pre-
cise role of caspase-1 in EAE, especially with regard to
OLG cell death, largely remains to be elucidated because
caspase-11 expression is eliminated in caspase-1 knockout
mice for unclear reasons (5).
Murine caspase-11 is a member of the caspase-1 subfam-
ily (6) and is required for caspase-1–induced apoptosis and
 
IL-1
 
b
 
 secretion (7). Physical interaction between caspase-
11 and caspase-1 is a critical step in the activation of
caspase-1 (7). Recent findings have shown that the sub-
strate specificity of caspase-11 is similar to caspase-9, and
that caspase-11 can promote the processing of caspase-3,
suggesting that caspase-11 works as the apical caspase in the
cascade that activates downstream executioner caspases un-
der pathological conditions (5). These findings suggest that
the activation of caspase-11 leads to the processing of both
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caspase-1 and -3. In this context, caspase-11 is thought to
be crucial in both inflammation and apoptosis in certain
pathological conditions. Because inflammation and OLG
injury are characteristic for MS and EAE, we expect that
caspase-11 plays pivotal roles in the progression of MS
and EAE.
In this study, we examined the role of caspase-11 in
OLG death in EAE. Caspase-11 is highly expressed in both
OLGs and infiltrating cells such as T lymphocytes in EAE
lesions. Although the number of OLGs was reduced in
EAE lesions, the proportion of apoptotic OLGs that ex-
pressed activated caspase-3 was increased compared with
spinal cord tissue from wild-type mice. The colocalization
of caspase-11 and activated caspase-3 in the OLGs suggests
that a pathway involving caspase-11 and -3 is important in
the execution of OLG death in EAE lesions. In vitro, cell
death induced by TNF-
 
a
 
, IFN-
 
g
 
, or anti-Fas antibody,
and the activation of caspase-3 by TNF-
 
a
 
 and IFN-
 
g
 
 were
all reduced in caspase-11–deficient OLGs, indicating that
caspase-11 functions in a cell-autonomous manner to regu-
late cell death. Caspase-11–deficient mice were signifi-
cantly resistant to the induction of EAE immunized with
MOG peptide. In a histopathological study of caspase-11–
deficient mice, the number of activated caspase-3–express-
ing and apoptotic OLGs was markedly decreased. Further-
more, the concentrations of IL-1
 
b
 
 and IFN-
 
g
 
 were also
reduced in the CNS, indicating the non–cell-autonomous
mechanism of caspase-11 in regulating the inflammatory
process. Our results suggest that caspase-11 plays a pivotal
role in the execution of OLG death and the neurological
manifestations of MS and EAE.
 
Materials and Methods
 
Mice. 
 
The caspase-11
 
2
 
/
 
2 
 
and caspase-11
 
1
 
/
 
2
 
 mice were de-
scribed previously (7). These heterozygous and homozygous
knockout mice have been maintained as a breeding colony at
Osaka University for 
 
z
 
3 yr. They were backcrossed for at least
five generations, usually eight generations, into C57BL/6 background
mice. 8-wk-old male and female C57BL/6 mice and 8–12-wk-
old female C57BL/6 mice in a late stage of pregnancy were ob-
tained from Charles River Laboratories.
 
Induction and Assessment of EAE. 
 
The Animal Welfare
Guidelines of Osaka University Medical School were followed
for all studies and experiments with mice. The procedure used to
induce EAE was described previously (3). In brief, mice were im-
munized with CFA (Difco) supplemented with 100 
 
m
 
g of rat
MOG
 
35–55
 
 peptide, and synthesized by Biologica with 4 mg/ml
 
Mycobacterium tuberculosis
 
 H37Ra (Difco). All C57BL/6 mice re-
ceived a subcutaneous injection of peptide in 0.1 ml of sterilized
PBS in the footpads of both hind feet. Immediately afterwards,
each mouse was also injected with 300 ng pertussis toxin (List Bi-
ological) in 0.25 ml PBS intravenously; this injection was re-
peated 48 h after the immunization. Clinical signs of disease were
graded on a scale of 0 to 6, with 0.5 points for intermediate clini-
cal findings, as follows: 0, normal; 1, weakness of the tail; 2, com-
plete loss of tail tonicity or abnormal gait; 3, partial hind limb pa-
ralysis; 4, complete hind limb paralysis; 5, forelimb paralysis or
moribund; and 6, death.
 
Western Blotting Analysis. 
 
Cervical/thoracic, and lumbar spi-
 
nal cords from control and EAE mice 20 d after immunization
were washed with PBS, homogenized in assay buffer (50 mM
Tris-HCl, pH 7.4, 1 mM EDTA, and 10 mM EGTA), and then
frozen immediately. After adding 10 
 
m
 
M digitonin, the homoge-
nate was incubated at 37
 
8
 
C for 10 min. The homogenate was
clarified by centrifugation at 15,000 rpm for 10 min. The clear su-
pernatant fraction was used for immunoblotting. Equal amounts
of protein (
 
z
 
15 
 
m
 
g) from the spinal cords were loaded on each
lane of a 12.5% polyacrylamide gel for SDS-PAGE. After electro-
phoresis, proteins were transferred onto an Immobilon-P mem-
brane (Millipore). Immunoblotting was carried out using rat
monoclonal anti–caspase-1 and -11 antibodies (a 1:100 dilution in
4% skim milk; reference 7), a rabbit polyclonal anti–caspase-3 an-
tibody (1:1,000 dilution; a gift from Dr. J.L. Goldstein, University
of Texas Southeastern Medical Center, Dallas, TX; reference 8),
and a mouse monoclonal anti–caspase-8 antibody (MBL; 1:500
dilution). Anti–rat, –rabbit, and –mouse IgGs conjugated with al-
kaline phosphatase (ALP, 1:750 dilution; Dako) were used as the
secondary antibodies. Signals were detected with an ALP buffer
containing bromo-chloro-indolyl phosphate (BCIP; Sigma-
Aldrich) and nitro blue tetrazolium (NBT; Sigma-Aldrich) as sub-
strates. Even loading was verified using a mouse monoclonal anti-
tubulin antibody (1:2,000 dilution; Sigma-Aldrich). Lysates made
from OLG primary cultures (see below) were dealt with the same
way. A quantitative analysis of the immunoreactive bands was
performed using computerized densitometry with a Scanning Im-
ager and ImageQuant
 
® 
 
software (Molecular Dynamics).
 
Immunohistochemistry of EAE Tissue. 
 
Grade 4 EAE and con-
trol non-EAE mice were perfused under anesthesia through the
left ventricle with 4% paraformaldehyde in PBS, and the cervical,
thoracic, and lumbar spinal cords were dissected. For cryosection-
ing, blocks of tissue were rinsed with PBS, cryoprotected in 30%
sucrose in PBS overnight at 4
 
8
 
C, embedded in OCT compound
(Tissue Tek), and frozen on dry ice. Cryostat sections (10 
 
m
 
m)
were cut and affixed to glass slides that were precoated with 3-ami-
nopropyltriethoxysilane (APS; Matsunami). Samples were in-
cubated with anti–caspase-1 antibody, anti-caspase-11 antibody,
rabbit polyclonal anti-activated caspase-3, or anti–caspase-8 anti-
body. We also used rabbit polyclonal anti-
 
p 
 
form of glutathione
 
S
 
-transferase (
 
p
 
GST) antibody (1:500 dilution; MBL), a marker
for OLGs, or mouse monoclonal anti-CD3
 
e
 
 antibody, a marker
of T cells (1:100 dilution; BD PharMingen). Samples were incu-
bated with antibodies diluted with blocking buffer for 1 h at room
temperature, then washed with PBS three times. The secondary
antibodies were FITC- and rhodamine-labeled anti–rat, –rabbit,
and –mouse IgGs (1:200; Chemicon). For double staining with
anti-
 
p
 
GST antibody and a rabbit polyclonal anti-activated
caspase-3 antibody (1:500 dilution; reference 9), we cut thin cry-
ostat sections (3 
 
m
 
m) and affixed adjacent sections to the same
glass slides. One section was stained with anti-
 
p
 
GST antibody
and the other with anti-activated caspase-3 antibody. We exam-
ined these samples with a fluorescence microscope (LSM-GB200,
Olympus; and LSM-510, ZEISS). For nuclear staining, samples
were incubated with 1 
 
m
 
M Hoechst 33342 dye for 10 min before
mounting. The nuclei of apoptotic cells were condensed and had
fragmented chromatin. Counting and analysis of the proportion of
caspase-positive OLGs and of the infiltrating T cells were per-
formed in three independent visual fields in a blind fashion.
 
Primary Cultures. 
 
Primary cultures of mouse OLGs were
prepared from C57BL/6 control and caspase-11 knockout mice.
Embryonic day 17–18 or 0-d-old pups were decapitated and their
brains were retrieved. Meninges were completely trimmed from
the brain submerged in HBSS (GIBCO BRL). The brains were 
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minced quickly in HBSS containing a trypsin-EDTA solution
(0.01% trypsin/ml and 0.1 mM EDTA; GIBCO BRL) and incu-
bated in a CO
 
2 
 
incubator at 37
 
8
 
C (5% CO
 
2
 
) for 5 min. Cells were
spun at 1,000 rpm for 5 min in a clinical centrifuge, and the cell
pellets were resuspended in DMEM containing 20% fetal bovine
serum (FBS) and penicillin/streptomycin at 100 U/ml and 0.1
mg/ml, respectively. The resuspended cells were plated in 25-
cm
 
2
 
 
 
D
 
-treated flasks (Nunc), using one flask for each brain disso-
ciated. After 7–9 d of culture, numerous pre–O-2A progenitor
clusters appeared overlying a confluent layer of astrocytes. O-2A
progenitors were obtained using an immunopanning method as
follows: 100-mm suspension culture dishes (Corning) were
coated with 20 
 
m
 
g of affinity-purified rabbit anti–rat IgG anti-
body (Zymed Laboratories) in 10 ml Tris buffer, pH 9.5, for 12 h
at 4
 
8
 
C. Dishes were washed three times with PBS and incubated
with rat anti–platelet-derived growth factor receptor 
 
a 
 
(PDG-
FR
 
a
 
) antibody (100 
 
m
 
g/dish; a gift from S.-I. Nishikawa, Kyoto
University, Kyoto, Japan; reference 10), a marker for O-2A pro-
genitors, in PBS for 1 h at room temperature. Dishes were then
washed twice with PBS. Suspensions of cells from the flasks were
added to the panning dishes. After 1 h of incubation at room
temperature, each plate was washed eight times with PBS with
gentle swirling to remove nonadherent cells. The remaining ad-
herent cells were detached by incubating with 0.25% trypsin
(Difco) diluted in HBSS for 10 min at 37
 
8
 
C, collected by centrif-
ugation at 1,000 rpm for 5 min, and resuspended in DMEM con-
taining 2% FBS, antibiotics, and Bottenstein and Sato’s (BS) sup-
plement (11). BS supplement includes 0.1 mg/ml transferrin, 0.1
mg/ml BSA, 60 ng/ml progesterone, 40 ng/ml sodium selenite,
40 ng/ml thyroxine, 30 ng/ml triiodothyronine, 16 
 
m
 
g/ml pu-
trescine, and 5 
 
m
 
g/ml insulin (all from Sigma-Aldrich). Cells
were plated onto dishes or microcoverslips (Matsunami) coated
with poly-
 
L
 
-lysine (mol wt 
 
.
 
70,000; ICN Biomedicals). We also
used a shaking method to obtain O-2A progenitors and mature
OLGs. The caps of the flasks were tightened and the flasks were
shaken by hand 
 
z
 
10–20 times. Such shaking detached O-2A
progenitors into the medium; the medium from the different
flasks was combined and spun at 1,000 rpm for 5 min, and the re-
sulting pellets were resuspended in S-MEM (GIBCO BRL). Cell
suspensions were spun again at 1,000 rpm for 5 min. The cell pel-
lets were resuspend in DMEM with 2% FBS, antibiotics, and BS
supplement. The suspension was passed through a glass pipette
gently 30 times and plated out. At 3–5 d of culture, O-2A pro-
genitors began to differentiate gradually into mature OLGs.
 
Genotyping of Caspase-11 Knockout Mice. 
 
Newborn mice
from a breeding pair of caspase-11
 
2
 
/
 
2
 
 or caspase-11
 
1/2
 
 mice
were decapitated, and whole brains were dissected. The cells of
each brain were plated in one 25-cm
 
2
 
 
 
D
 
-treated flask (Nunc) us-
ing the primary culture procedure described above. PCR was
used to genotype caspase-11 knockout mice. Genomic DNA was
isolated from tails in lysis buffer (100 mM Tris-HCl, pH 8.5, 5
mM EDTA, 0.2% SDS, 200 mM NaCl, 100
 
 m
 
g proteinase
K/ml). The primer sequences used for the PCR were as follows:
 
SY-21
 
, 5
 
9
 
-GGCATGGAGTCAGAGATGAAAGAC-3
 
9
 
; 
 
SY-22
 
,
5
 
9
 
-GCCCATGTGGCATTACCTGCCAGC-3
 
9
 
; 
 
SYKO
 
, 5
 
9
 
-
AGATCTACACCTCTGCACAACTGGGGT-3
 
9
 
; and 
 
PJK
 
, 5
 
9
 
-
TGGCGCTACCGGTGGATGTGGAATGTG-3
 
9
 
.
The wild-type genome of 
 
caspase-11
 
 could be detected using
 
SY-21
 
 and 
 
SY-22
 
 (an 
 
z
 
200-bp PCR product), and the mutant
caspase-11 gene could be detected using 
 
SYKO
 
 and 
 
PJK
 
 (an
 
z
 
600-bp PCR product). The following conditions were used for
the PCR reaction: 1
 
3
 
 ExTaq PCR buffer (Takara), 0.06 mM
dNTPs, 25 pmol of each primer, 0.5 U of ExTaq DNA poly-
 
merase (Takara) in a total volume of 20
 
 m
 
l. The DNA was dena-
tured at 94
 
8
 
C for 2.5 min, annealed at 55
 
8
 
C for 1.5 min, and
elongated at 72
 
8
 
C for 1 min with 35 cycles.
 
OLG Viability Assay.
 
After 48–72 h of primary culture of
OLG, human recombinant TNF-
 
a
 
 (200 ng/ml; Sigma-Aldrich),
anti-Fas antibody (Jo2, 200 ng/ml; BD PharMingen), or recom-
binant mouse IFN-
 
g
 
 (100 U/ml; Genzyme) were administered
to each well of the mature caspase-11
 
2
 
/
 
2
 
 or caspase-11
 
1
 
/
 
2
 
 
 
OLGs.
After a 72-h incubation, cells were homogenized in assay buffer
for immunoblotting (see above) or fixed with 4% paraformalde-
hyde in PBS for 10 min. The samples were washed with PBS
three times, incubated with rabbit polyclonal anti–myelin basic
protein
 
 (
 
MBP) antibody (1:100 dilution; reference 12) for 1 h at
room temperature, then washed with PBS three times. Samples
were incubated with ALP-conjugated anti–rabbit IgG antibody
for 1 h at room temperature, then washed with PBS three times.
MBP was detected with an ALP buffer containing BCIP and
NBT as substrates.
 
ELISA for Cytokine Secretion.
 
The whole brain and spinal
cord (cervical to lumbar) in a mouse with EAE, a postimmuniza-
tion day–matched caspase-11 knockout, and an uninjected con-
trol mouse were dissected and homogenized in PBS, then frozen
immediately. IL-1
 
b
 
 and IFN-
 
y
 
 were quantified using a mouse
ELISA kit (Endogen). The absorbance was read at 450 nm with a
Biolumin 960 fluorescence/absorbance microassay reader (Mo-
lecular Dynamics). The data for each cytokine were collected and
analyzed in three independent measurements.
 
Statistical Methods. 
 
The results are expressed as the mean 
 
6
 
SEM. The probability of statistical differences between experi-
mental groups was determined by a Student’s 
 
t
 
 test, as indicated.
 
Results
 
Expression of Caspases in the Spinal Cord of Mice with
EAE. EAE is characterized by inflammation and demy-
elination in the CNS. Like MS, EAE shows a perivascular
inflammatory infiltration in the spinal cord and brain that is
composed primarily of T cells and macrophages. We previ-
ously reported observing apoptotic OLGs in EAE lesions
(3). To investigate the expression of caspases in EAE le-
sions, protein lysates were prepared from the upper (cervi-
cal and thoracic) and lower (lumbar) spinal cord of mice 20 d
after MOG injection. Immunoblots probed with anti-
bodies to caspase-1, -11, and -8 revealed that the expres-
sion of these caspases was strongly elevated in spinal cord
lysates from EAE mice (Fig. 1 A). We also performed im-
munohistochemistry using antibodies against caspases. As
shown in Fig. 1, B–E, the caspases were expressed in very
few cells in spinal cord sections from normal control mice,
but were all strongly expressed in many cells in mice with
grade 4 EAE (Fig. 1, F–I). Strong immunoreactivity against
caspase-1, -11, and activated caspase-3 was found at the
outer surface of the spinal cord and in the white matter.
Caspase-8 expression was largely confined to the outer sur-
face of the white matter. Next, we examined immuno-
staining using antibodies for several caspases together with a
cell type–specific marker, an antibody to the anti-pGST, a
marker for mature OLGs. Because pGST labeling was114 Caspase-11 in Autoimmune-mediated Demyelination
more intense in the cell body and the proximal processes of
mature OLGs (13, 14), we could detect and count mature
OLGs more easily than by using other antibodies that label
OLGs in a more general way. Together with the results of
Fig. 1, F–I, our observations show that many OLGs in the
white matter of the lumbar spinal cord of mice with EAE
strongly expressed caspase-1, -11, and activated caspase-3,
but that few expressed caspase-8 (Fig. 1, J–M).
Caspase-1 Family Member–positive OLGs Expressed Acti-
vated Caspase-3 in the EAE Lesions.  Previously we de-
fined that OLGs in the spinal cords of mice with severe
EAE expressed caspase and some of them had undergone
apoptosis (3). Approximately 10% of OLGs in the spinal
cord lesions with EAE showed apoptotic nuclear morphol-
ogy (3). Since one of the hallmarks of apoptosis is the acti-
vation of caspase-3, we tested whether OLGs in EAE le-
sions underwent apoptosis via caspase-3 activation in the
immunohistochemistry. We prepared sequential sections of
lumbar spinal cord from an EAE mouse (3-mm thick), and
performed immunostaining with anti-activated caspase-3
antibody on one section and with anti-pGST antibody on
an adjacent section. We found that many OLGs in EAE le-
sions expressed activated caspase-3. Some of them revealed
a condensed or fragmented nucleus by Hoechst 33342 nu-
clear staining. Then we calculated the ratio of OLGs that
expressed activated caspase-3 and OLGs that showed apop-
Figure 1. Caspases are expressed in the
OLGs of the white matter of the lumber
spinal cord of mice with EAE. (A) Immu-
noblot analysis of the cervical/thoracic and
lumbar spinal cord lysates from EAE mice
using anti–caspase-8, -1, -11, and -3 anti-
bodies. Even loading was demonstrated us-
ing an antitubulin antibody. Caspase-8, -1,
and -11 were markedly induced in the lum-
bar/cervical and thoracic spinal cord of EAE
(grade 4) mice. (B–E) Immunohistochemi-
cal analysis using anticaspase antibodies of
the lumbar spinal cord from adult female
uninjected control mice. Bar, 50 mm. (F–N)
Double immunohistochemical analysis of
the lumbar spinal cord from EAE mice us-
ing anticaspase antibodies (F–I) and pGST,
a specific marker of mature OLGs (J–M,
from EAE mice; N, from nonEAE control
mouse). Although little expression of
caspase-1, -11, -8, or activated caspase-3
was detected in the normal lumbar spinal
cord, these were strongly expressed in EAE
mice. Caspase-8 was not expressed in
pGST1 OLGs. For double staining with
anti-activated caspase-3 (H) and anti-pGST
(L) antibodies, thin cryostat sections (3 mm)
were made. One section was stained with
anti-pGST antibody and an adjacent one
was stained with anti-activated caspase-3
antibody. Arrows indicate representative
OLGs that express caspase-1, -11, and acti-
vated caspase-3. Bar, 50 mm.115 Hisahara et al.
totic nuclear degeneration in the observation of multiple
microscopic visual fields. Approximately 45% of pGST1
OLGs expressed activated caspase-3, and 10% of OLGs
showed condensed or fragmented nuclei, indicating that
these cells were undergoing apoptosis (Fig. 2, A and B).
The ratio of caspase-3–expressing OLGs that showed nu-
clear degeneration was also z10%, so we concluded that
almost all of the apoptotic OLGs expressed activated
caspase-3. We next compared the expression of caspase-1
subfamily members in OLGs of the spinal cord of mice
with EAE. First, we calculated the ratio of OLGs that ex-
pressed caspase-1 or -11. Then we compared the ratio of
activated caspase-3 expression between caspase-1– or -11–
positive OLGs in the lesions of EAE. We found that many
OLGs that were positive for both caspase-11 or -1 and acti-
vated caspase-3 existed in the lumbar spinal cord of EAE
Figure 2. Caspase-11–positive
OLGs express activated caspase-3
and undergo cell death in EAE le-
sions. (A) Immunohistochemical
staining with anti-pGST and anti-
activated caspase-3 antibodies. The
left panel shows a section of the
white matter of a lumbar spinal cord
from a mouse with EAE, stained
with anti-pGST antibody; the mid-
dle panel shows an adjacent section
stained with anti-activated caspase-3
antibody. The right panel shows nu-
clear staining with Hoechst 33342.
Note that many of the caspase-3–
positive OLGs had an intact nucleus,
as seen with Hoechst 33342 (arrow),
but z10% of the caspase-3–positive
OLGs appeared to be apoptotic (ar-
rowhead). Bar, 20 mm. (B) The ratio
of apoptotic OLGs in the lumbar
spinal cord of EAE mice. The data
give the percentage of activated
caspase-3–expressing OLGs of the
total number of OLGs, the percent-
age of apoptotic nuclear OLGs of
the total number of OLGs, and the
percentage of apoptotic nuclear
OLGs of the total number of acti-
vated caspase-3–positive OLGs
counted in three independent visual
fields selected in a blind manner.
Values are means 6 SEM (error
bars). (C) Activated caspase-3–posi-
tive OLGs express caspase-1 and
-11. One section was stained with
anti-pGST antibody and an adjacent
one with anti–caspase-1 or -11 anti-
bodies and anti-activated caspase-3
antibody. In EAE lesions, pGST1
OLGs highly expressed caspase-1,
-11, and activated caspase-3. Arrows
indicate activated caspase-3–positive
OLGs that also expressed caspase-1
or -11. Arrowheads indicate OLGs
that expressed neither activated
caspase-3 nor -1. Bar, 20 mm. (D)
Relative number of caspase-1 sub-
family–positive OLGs in the white
matter of the lumbar spinal cord
from an EAE mouse. The data give
the percentage of caspase-1– or -11–
positive cells of the total number of
pGST1 cells and the percentage of
activated caspase-3–positive OLGs
of the total number of caspase-1– or
-11–expressing OLGs counted in
three independent visual fields se-
lected in a blind manner. Values are
means 6 SEM (error bars).116 Caspase-11 in Autoimmune-mediated Demyelination
(Fig. 2, C and D). Approximately 50% or fewer of the
OLGs in EAE lesions were caspase-1–positive and .70%
were caspase-11–positive (Fig. 2 D). Approximately 50% of
the activated caspase-3–positive OLGs expressed caspase-
11 and z40% of the activated caspase-3–positive OLGs ex-
pressed caspase-1. Colocalization of caspase-1 subfamily
with activated caspase-3 suggests the involvement of this
family member in activation of caspase-3 in OLGs.
Caspase-11 Is Essential in Cytokine-induced OLG Cell
Death.  To evaluate a possible role for caspase-11 in OLG
cell death, we prepared purified OLGs as a primary culture
from both wild-type and caspase-112/2 mice, and treated
them with TNF-a or IFN-g. After a 72-h incubation, we
made cell lysates from the cultures and used them for im-
munoblotting with anti-caspase antibodies. In the lysates
from wild-type OLGs, the expression of caspase-1, -11,
and the processed form of caspase-3 was induced by TNF-a
and IFN-g (Fig. 3 A). In contrast, caspase-8 was not de-
tected in either the cytokine-treated or the untreated ly-
sates. These results were consistent with the immunohis-
tochemical results shown in Fig. 1, I and M. Interestingly,
even though caspase-1 expression was induced by cyto-
kines in the caspase-112/2 OLGs, the amount of processed
caspase-3 was less than in wild-type OLGs. This result in-
dicates that caspase-11 plays a more important role in acti-
vating caspase-3 than does caspase-1 in cytokine-induced
OLG cell death. We next prepared purified OLGs from
both caspase-112/2 and caspase-111/2 mice and treated
them with TNF-a, IFN-g, or the anti-Fas antibody Jo2.
After a 72-h incubation, the cells were fixed and mature
OLGs were identified by staining with an anti-MBP anti-
body to allow us to quantify the changes in the number of
OLGs. Caspase-11–deficient OLGs were almost com-
pletely resistant to the cell death induced by IFN-g and the
anti-Fas antibody Jo2, and partially resistant to that induced
by TNF-a (Fig. 3, B and C). These results strongly suggest
that caspase-11 is involved in promoting the OLG cell
death induced by cytotoxic cytokines or Fas.
Figure 3. Caspase-11 plays an important role in cyto-
kine-induced OLG cell death. (A) Immunoblot analysis of
OLG lysates from wild-type control and caspase-112/2
mice using anti–caspase-1, -11, -8, and -3 antibodies.
Even loading was demonstrated using an antitubulin anti-
body. Bar graph represents a densitometric analysis show-
ing the relative amount of the processed caspase-3, pro-
duced by the treatment of cytokines between control and
caspase-11 knockout mice, expressed as a percentage. (B)
Primary cultured OLGs from caspase-111/2 and caspase-
112/2 mice with or without the addition of 100 ng/ml
IFN-g. Many MBP1 OLGs from caspase-112/2 mice
were observed 72 h after IFN-g administration. Original
magnification: 1003. (C) Percentages of cultured cells that
represented live OLGs, calculated by counting MBP1
OLGs. TNF-a (200 ng/ml), IFN-g (100 U/ml), and anti-
Fas antibody (100 ng/ml) were administered to OLG cul-
tures, which were fixed z72 h later. In each experiment,
the OLGs collected from each independent well were
counted, and the relative percentage of MBP1 cells was
expressed as the mean 6 SEM (error bars). Data were col-
lected from three independent experiments. **P , 0.01 at
each distance (Student’s t test).117 Hisahara et al.
Caspase-11–deficient Mice Are Resistant to EAE.  To fur-
ther explore the role of caspase-11 in the progression of
EAE, we studied the susceptibility of caspase-112/2 mice to
MOG peptide–induced EAE. Most wild-type mice de-
velop severe hind limb paralysis 20 d after rat MOG35–55
peptide immunization (Fig. 4 A). The incidence of EAE in
control mice was 90% (9/10), with a mean peak of clinical
severity of grade 3.8 6 0.4 (see Materials and Methods, In-
duction and Assessment of EAE). However, the incidence
and severity of EAE in caspase-112/2 mice were signifi-
cantly reduced (21% incidence, 3/14; severity: 0.679 6
0.428; P , 0.001). We performed immunohistochemistry
with anti-pGST and anti-activated caspase-3 antibodies on
the lumbar spinal cord from a caspase-112/2 mouse at 20 d
after immunization. The number of activated caspase-3–
expressing OLGs was ,50% of a wild-type mouse (Fig. 4,
B and C). There were very few apoptotic OLGs in the white
matter of the caspase-112/2 mouse, as determined using
Hoechst 33342 staining. Only ,1% of OLGs showed apop-
totic and expressed activated caspase-3 (Fig. 4 C). Taken to-
gether, these results indicate that caspase-11 plays a significant
role in the susceptibility of OLGs to EAE induction.
Involvement of Caspase-11 in the Production of Inflammatory
Cytokines.  Caspase-1 subfamily molecules are crucially
involved in immune-mediated inflammation because of
their role in regulating the cellular export of cytokines such
as IL-1b and IL-18 (15). Fig. 5, A–D, shows that CD3e1
infiltrating T cells express caspases-1 and -11. However,
spinal cords from an immunized caspase-11–deficient and a
nonimmunized wild-type mouse showed little or no infil-
tration of T cells (Fig. 5, E and F). To explore the role of
caspase-11 in the cytokine production of EAE, we ana-
lyzed the concentration of several cytokines in the CNS
with MOG peptide–immunized wild-type and caspase-
112/2 mice. The brain and spinal cord of knockout and
wild-type mice were isolated 20 d after MOG peptide in-
jection. For controls, the tissues of an age- and sex-
matched uninjected female wild-type mouse were isolated
the same way. The concentrations of IL-1b and IFN-g in
the lysates from these tissues were quantified by ELISA
(Fig. 5 G). The amounts of these cytokines were markedly
increased in the brain and spinal cord of mice with grade 4
EAE compared with samples from uninjected wild-type
mice. The concentrations of these cytokines were dramati-
cally reduced in the samples from caspase-112/2 mice.
These results suggest that caspases-1 and -11 are expressed
in infiltrating T cells and that the expression of caspase-11
is involved in the production of IL-1b and IFN-g in the
CNS of mice with EAE.
Discussion
In this study, we show that caspase-11 plays a critical role
in the susceptibility of mice to EAE induction. Caspase-
Figure 4. Caspase-11–deficient mice are less susceptible to EAE induc-
tion. (A) Daily mean clinical course and severity of the EAE induced by
MOG35–55 peptide for each genotype. Clinical signs of the disease were
monitored daily, beginning on day 7, and were graded on a scale from 0
to 6. (B) Immunohistochemical staining of the white matter of the lumbar
spinal cord with anti-pGST and anti-activated caspase-3 antibodies in
caspase-112/2 mice in adjacent thin sections. Nuclear staining using Hoechst
33342 was also performed. Note that the numbers of both activated
caspase-3–positive OLGs were markedly less in caspase-112/2 mice than
in wild-type mice with grade 4 EAE. Compare with the similar staining
of wild type (Fig. 2 A). Arrows indicate OLGs that express activated
caspase-3. Bars: 20 mm. (C) The percentage of activated caspase-3–posi-
tive cells and the percentage of apoptotic OLGs in wild-type versus
caspase-112/2 mice 20 d after immunization. Data give the percentage of
activated caspase-3–positive cells of the total number of OLGs, the per-
centage of apoptotic nuclear OLGs of the total number of OLGs, and the percentage of cells showing apoptotic nuclear features of the total number of
activated caspase-3–positive OLGs counted in three independent visual fields selected in a blind manner. Values are means 6 SEM (error bars).118 Caspase-11 in Autoimmune-mediated Demyelination
11’s role in OLG cell death is thought to be mediated in
two ways in autoimmune demyelinating diseases. One is
the so-called “cell-autonomous effect,” in which processed
caspase-11 in OLGs activates caspase-3 and results in cell
death via specific cell death pathways. The other is the
“non–cell-autonomous effect” in which caspase-11 ex-
pressed by infiltrating cells regulates the production of cy-
totoxic cytokines (Fig. 6). This dual role of caspase-11 may
be partly responsible for the characteristic relapse and re-
mission of autoimmune demyelinating diseases that evolve
over a long period into a chronic form of disability without
clear-cut exacerbation.
In a previous study, we investigated the clinical course
and severity of EAE in mice that express the antiapoptotic,
caspase-inhibitory protein p35 specifically in mature OLGs
(3). The incidence and severity of EAE in these transgenic
mice are markedly reduced (maximum clinical score of
z1.5) compared with control mice (maximum clinical
score of z4.0). Interestingly, the clinical severity of the
caspase-11–deficient mice is less than that of the p35-
expressing transgenic mice. As shown in Fig. 4 A, the max-
imum clinical score in the caspase-11 knockout mice was
,1. These results suggest that absence of caspase-11 results
not only in decreasing OLG cell death but also in changing
the ability of the immune system to produce cytokines that
are toxic to OLGs.
It is important to discuss the role of the caspase-1 sub-
family in directly killing target cells in certain diseases. We
examined the cell-autonomous function of caspase-11 in
the regulation of OLG cell death that was induced by treat-
ment with TNF-a, IFN-g, and an anti-Fas antibody. We
demonstrated here that OLGs purified from caspase-11
knockout mice show complete resistance against IFN-g
and anti-Fas antibody–induced cell death (Fig. 3 C). These
results suggest that caspase-11 is responsible for mediating
IFN-g– and Fas-induced OLG cell death. We could ob-
serve partial resistance against TNF-a–induced cell death
in caspase-11 knockout OLGs. In this case, caspase-9/
Apaf-1/cytochrome c pathway might also play roles in
OLG cell death because we previously showed that OLG’s
mitochondrial membrane potential was rapidly reduced by
TNF-a (16). Under pathological conditions, the expres-
sion level of activated caspase-3 was lower in caspase-11
knockout OLGs than in wild-type OLGs in vitro and in
vivo (Fig. 3 A and Fig. 4, B and C). Recently, it was dem-
onstrated that recombinant caspase-11 directly cleaves and
Figure 5. Alteration in cytokine production in the CNS of immunized caspase-11–
deficient mice. (A–D) Double immunohistochemical staining with anti-CD3e (A and
B) and anti–caspase-1 or -11 (C and D) antibodies in the lumbar spinal cord of wild-
type mice with grade 4 EAE. Note that the infiltrating T cells strongly expressed
caspase-1 and -11. (E) The spinal cord of a caspase-112/2 mouse 20 d after immuniza-
tion showed little infiltration of CD3e1 cells. (F) Immunostaining of the lumbar spinal
cord with anti-CD3e antibody in an uninjected adult female mouse. Bars, 50 mm. (G)
Quantitative measurement of cytokines in the CNS by ELISA. Wild-type and caspase-
112/2 mice were killed 20 d after immunization as were age- and sex-matched unin-
jected wild-type mice. Lysates from the brain (Br) and spinal cord (SpC) were collected
and tested for IL-1b and IFN-g, using an ELISA kit. Results are shown as the mean 6
SD from three independent measurements. **P , 0.01 at each distance (Student’s t test).
*P , 0.05 at each distance (Student’s t test).119 Hisahara et al.
activates procaspase-3 in vitro (5). Caspase-11 preferentially
cleaves the site (I/L/V/P)EHD, which is similar to sites
used by upstream caspases, such as caspase-8 and -9, that
activate caspase-3. All of these data strongly suggest that
caspase-11 is upregulated in OLGs and activates caspase-3,
leading to OLG death in EAE. Caspase-3 activation
through caspase-8 or -9 is well characterized. In addition to
these pathways, our data strongly suggest that a pathway in-
volving caspases-11 and -3 seems to play important roles in
certain types of pathologic cell death, including in MS and
EAE. Subpopulations of neurons and OLGs in ischemic le-
sions strongly express caspase-11 in wild-type mice, and
caspase-11–deficient mice have a reduced number of apop-
totic cells and a defect in caspase-3 activation after middle
cerebral artery occlusion, a mouse model of stroke (5, 17).
The size of the damaged area and the resulting functional
damage due to experimental ischemia are significantly re-
duced in caspase-1 dominant negative mutant mice (18)
and by administration of caspase-1 subfamily–specific in-
hibitors in wild-type mice (19). These results suggest that
the caspase-1 subfamily, especially caspase-11, plays a piv-
otal role in the pathogenesis (including executing the cell
death of target cells) of not only MS and EAE but also
acute progressive neurological diseases such as cerebral in-
farction.
Caspase-8 plays a central role in the cytokine-mediated
caspase cascade. Multimerization of TNF receptors and
Fas initiates the recruitment of various adapter proteins
through death domain interactions; this complex directly
binds to and promotes the transcatalytic activation of
caspase-8 (20, 21). Whereas caspase-8 was upregulated in
CNS lysates from mice with EAE (Fig. 1 A), it was not de-
tected in OLGs that were exposed to cytotoxic cytokines
in primary cultures (Fig. 4 A). In a study using rat OLGs
from long-term cultures, procaspase-8 was expressed and
activated after treatment with apoptotic stimuli such as
staurosporine or nerve growth factor (NGF; reference 22).
However, the characteristics of OLGs differ with different
culture conditions. For example, NGF does not induce
OLG cell death in our cultures; rather, it prevents TNF-a–
induced OLG cell death (16). Our in vivo and in vitro ob-
servations indicate that caspase-8 has little involvement in
cytokine-induced OLG cell death in EAE because we
failed to detect caspase-8 in either cultured OLGs (Fig. 3
A) or OLGs populating EAE lesions (Fig. 1, I and M).
In this study, we observed many CD3e1 T cells in the
white matter of wild-type mice with severe EAE, although
very few such cells were found in caspase-112/2 mice (Fig.
5, A, B, and E). We previously showed that very few infil-
trating cells are observed in the spinal cord lesions of EAE
mice that express the antiapoptotic protein p35 in mature
OLGs (3). We presume that prevention of OLG cell death
inhibits inflammatory reaction and subsequent tissue injury.
Inflammation is considered to be the most important cause
of tissue injury in several diseases. Using a murine model of
renal ischemia, administration of a caspase inhibitor and an-
tiapoptotic agents at the time of reperfusion prevents the
early onset of not only renal apoptosis but also inflamma-
tion and tissue injury (23). Treatment with a caspase-1 sub-
family–specific inhibitor in the murine model of cerebral
ischemia results in a significant reduction in the infarct vol-
ume and the levels of the proinflammatory cytokines IL-1b
and TNF-a (24). These results strongly suggest that apop-
tosis of target cells is a critical event that can trigger subse-
quent inflammation and lead to the deterioration of the
clinical manifestation of diseases due to tissue injury.
Members of the caspase-1 subfamily play important roles
in both apoptosis and inflammatory responses (7, 25). We
found that caspases-1 and -11 were highly expressed in
CNS lesions of mice with EAE, especially in CD3e1 T
cells. Caspase-1 is the protease responsible for processing
proIL-1b to mature IL-1b. The IL-1 receptor antagonist
(IL-1ra) inhibits the apoptosis induced by trophic factor
deprivation in primary neurons, as well as by TNF-a in fi-
Figure 6. The role of caspase-11 in the pathogenesis of
EAE. Caspase-11 has two effects, cell-autonomous and
non–cell-autonomous. In the cell-autonomous effect,
caspase-11 in OLGs is processed and activated by several
unknown signals that could be derived from the stimula-
tion of cytotoxic cytokines such as IFN-g and TNF-a.
Caspase-11 activation results in OLG apoptosis via
caspase-3 activation. In the non–cell-autonomous effect,
caspase-11, which is a member of the caspase-1 subfamily,
activates caspase-1, which regulates the maturation of cy-
tokines, including IL-1b and IGIF. When inflammation
occurs in the CNS, infiltrating cells from beyond the
blood-brain barrier proliferate and produce cytokines that
are cytotoxic to OLGs.120 Caspase-11 in Autoimmune-mediated Demyelination
broblasts (26). Treatment with rhIL-1ra during the effector
phase of EAE significantly reduces the clinical signs of EAE
(27). IL-1 is a potent mitogen for astroglia but has no effect
on OLGs, suggesting that IL-1, released by inflammatory
cells, may promote the formation of astroglial scars in the
damaged mammalian brain (28). It is possible that IL-1b
released by infiltrating macrophages promotes gliosis and
the progression of MS.
Previous studies revealed that caspase-1 can also process
proIFN-g inducing factor (proIGIF or proIL-18), thereby
regulating the production of IFN-g, which is involved in
the pathogenesis of inflammatory processes (15, 29). IFN-g
and TNF-a are also involved in reactive astrogliosis (30).
The cytotoxicity of microglia for OLGs can be enhanced by
IFN-g and blocked by an anti–TNF-a antibody (31). A
single microinjection of TNF-a or IFN-g into the lum-
bosacral spinal cord of rats produces an inflammatory re-
sponse with a remarkably similar pattern to that observed
during EAE (32). IFN-g and IL-1b alone do not induce
TNF-a production from astrocytes; however, combined
treatment with IFN-g and IL-1b results in a striking syner-
gistic effect on astrocyte TNF-a production (33). It is possi-
ble that activated caspase-1 and -11 in infiltrating CD3e1 T
lymphocytes mediate the production of IL-1b and IFN-g,
and that these cytokines mediate their cytotoxicity against
the OLGs in EAE lesions through TNF-a. By activating
caspase-1, caspase-11 is likely to promote OLG cell death
through the production of cytokines, and thereby to elicit
their effects in a non–cell-autonomous manner (Fig. 6).
The role of cytokine in the pathogenesis of autoim-
mune-mediated demyelinating diseases including EAE is
still unclear and the cytotoxic effect against OLG in the le-
sion of diseases is controversial. In an in vitro study, cul-
tured OLGs undergo cell death induced by cytokines such
as TNF-a, IFN-g, and lymphotoxin (12, 34–36). Al-
though these results indicate that cytokines play a critical
role for cytotoxicity of OLG, some previous reports show
that some of them are not essential in an in vivo study for
the induction and expression of inflammatory and demyeli-
nating lesions. Mice lacking both TNF-a and lympho-
toxin-a (37) or lacking TNF-a (38) develop severe neuro-
logical impairment with high mortality and extensive
inflammation and demyelination. Mice lacking IFN-g re-
ceptor also develop EAE with high morbidity and mortal-
ity with severe inflammation and demyelination of the
CNS (39). These observations suggest that these cytokines
are potent protective for inflammation and demyelination.
However, Dowling et al. (2) used the in situ TdT-medi-
ated dUTP nick end labeling (TUNEL) technique and in-
dicated that 14–40% of the dying cells in the acute and
chronic MS plaques were OLG; there is little evidence that
cytokines directly kill OLGs in demyelinating diseases. It is
possible that cytokines play different roles in the various
periods, such as the initiation and progression of autoim-
mune demyelinating diseases, so further experiments are
required to elucidate the precise mechanisms of cytokines
involved in producing the inflammation and demyelina-
tion.
Caspase-11 is required for the activation of caspase-1 (7).
Recently, a reduction in MOG peptide–induced EAE inci-
dence and severity was reported in caspase-1 knockout
mice (4). However, we found that the caspase-1–deficient
mice used in this study (40) are also deficient in their ex-
pression of caspase-11, for unknown reasons (5). Our
caspase-112/2 mice, which are in a C57BL/6 background,
definitely express caspase-1 (Fig. 4 A), so we have con-
firmed that the reduced incidence and severity of EAE and
lowered production of cytokines result from caspase-11 de-
pletion. Thus, treatment with caspase-11 inhibitors could
be a useful therapy for MS and other diseases in which in-
flammation and cell death play a role.
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